Corify selected as the most promising start-up in the I Life Sciences investor capital forum27 February, 2020
Corify team continues growing!30 June, 2020
UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.
Andreu Climent, CEO of Corify Care
Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.
This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.